Xalkori 250 mg (Crizotinib CAPSULE) 250 MG

XALKORI 250 MG capsules contain crizotinib, a targeted therapy used in cancer treatment. This oral medication is designed to inhibit specific proteins involved in cancer cell growth.

Strength

250 MG

Pack Size

Manufacturer / TM Owner

PFIZER CANADA ULC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

XALKORI 250 MG capsules are primarily used in the treatment of certain types of cancer. The active ingredient, crizotinib, targets proteins that play a role in cancer cell proliferation. This medication is often prescribed for patients with specific genetic markers associated with their cancer. What is XALKORI used for? It is commonly used in the management of non-small cell lung cancer and other malignancies where the targeted proteins are overexpressed.

Side Effects

Common effects of XALKORI 250 MG capsules may include nausea, vomiting, and diarrhea. Some patients may experience fatigue, vision changes, or swelling. These effects can vary in severity and duration. It is important to monitor for any unusual symptoms and consult a healthcare provider if they persist or worsen.

Precautions & Warnings

XALKORI 250 MG capsules should be handled with care. Store the medication at room temperature, away from moisture and heat. Keep the capsules out of reach of children and pets. Always follow the prescribed dosage and administration instructions provided by your healthcare provider.

Avoid Interactions

XALKORI 250 MG capsules may interact with certain medications, including those that are metabolized by the liver. Alcohol and other substances that affect liver enzymes can also impact the effectiveness of crizotinib. It is important to inform your healthcare provider about all medications and supplements you are taking to avoid potential interactions.

Frequently Asked Questions

XALKORI is used in the treatment of certain types of cancer, particularly those involving specific genetic markers.

XALKORI capsules are taken orally, typically with or without food, as directed by your healthcare provider.

Common side effects may include nausea, vomiting, diarrhea, fatigue, vision changes, and swelling.

It is generally advised to avoid alcohol while taking XALKORI, as it may interact with the medication.

Store XALKORI capsules at room temperature, away from moisture and heat, and keep them out of reach of children.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.